News & Publications

Press Releases

Oct 1, 2019

Jnana Therapeutics Appoints Caroline Stark Beer as Chief Business Officer

Boston, Mass., October 1, 2019 – Jnana Therapeutics, a biotechnology company targeting the solute carrier (SLC) family of metabolite transporters to treat underserved diseases, today announced the appointment of Caroline…

Read More >

Apr 5, 2019

Jnana Therapeutics Appoints Donald Nicholson, Ph.D., as Chair of its Board of Directors

Boston, Mass., April 5, 2019 – Jnana Therapeutics today announced the appointment of Donald Nicholson, Ph.D., an accomplished scientist and executive, as chair of its Board of Directors. Don…

Read More >

Dec 20, 2018

Jnana Therapeutics Expands Board of Directors and Forms Scientific Advisory Board

Stuart Schreiber, Ph.D. and Brian Cali, Ph.D. appointed to Board Inaugural SAB comprises renowned leaders in the investigation of disease biology and applications to drug discovery and development Boston,…

Read More >

Nov 6, 2018

Jnana Therapeutics Announces Appointment Of Joanne Kotz, Ph.D. As Chief Executive Officer

Boston Mass. – Nov. 6, 2018 – Jnana Therapeutics today announced that Joanne Kotz, Ph.D., a company co-founder, has been named Chief Executive Officer. Dr. Kotz has served as…

Read More >

Oct 9, 2018

Neurocrine Biosciences And Jnana Therapeutics Enter Strategic Collaboration To Discover Novel Medicines To Treat Central Nervous System Disorders

Partnership Leverages Neurocrine’s Expertise in Neuroscience and Jnana’s Proprietary Drug Discovery Platform Targeting the Solute Carrier Family of Transporters SAN DIEGO and BOSTON, Oct. 9, 2018 – Neurocrine Biosciences,…

Read More >


Apr 16, 2020

Scripps Research expands international effort to rapidly repurpose existing drugs against COVID-19

Scripps Research, April 2020

Oct 14, 2018

Jnana Therapeutics tries to take on an untapped class of proteins

Chemical and Engineering News, October 2018